This would validate estimates of risk associated with specific types or sets of lipids and ApoA1-or ApoB-containing lipoproteins identified in cross-sectional studies and contribute to a mechanistic understanding of AD- or MCI-risk. The gene discussed is APOA1; the disease is Alzheimer disease.